1-10 of 10
Jeries Kort
Close
Sort by
Journal Articles

Assessing the Stanford Integrated Psychosocial Assessment for Transplantation (SIPAT) in Risk-Stratifying Multiple Myeloma Patients for Autologous Stem Cell Transplantation

Jeries Kort, Sathya Sri Areti, Nikolas Naleid, Brenda W Cooper, Ehsan Malek
Journal: Blood
Blood (2023) 142 (Supplement 1): 6706.
https://doi.org/10.1182/blood-2023-190931
Published: 2023
Journal Articles

Assessing a New Paradigm in Defining High Risk Precursor Disease State for Patients with Plasma Cell Dyscrasia: Fluctuating Monoclonal Protein

Rishi Chopra, Pingfu Fu, Jeries Kort, Ravikumar Kyasaram, Ehsan Malek
Journal: Blood
Blood (2023) 142 (Supplement 1): 6774.
https://doi.org/10.1182/blood-2023-172709
Published: 2023
Journal Articles

A Risk Model to Predict the Longitudinal Decline in Creatinine Clearance Among Patients with Precursor Plasma Cell Dyscrasia with Baseline Chronic Kidney Failure

Jeries Kort, Pingfu Fu, Leland Metheny, Ravi Kyasaram, James J. Driscoll, Ehsan Malek
Journal: Blood
Blood (2022) 140 (Supplement 1): 13176–13177.
https://doi.org/10.1182/blood-2022-162641
Published: 2022
Journal Articles

Artificial Intelligence to Assess the Systemic Impact of Malignant Plasma Cell Clone in Patients with Plasma Cell Dyscrasia

Ehsan Malek, Jeries Kort, Gi-Ming Wang, Curtis Tatsuoka, James J. Driscoll
Journal: Blood
Blood (2022) 140 (Supplement 1): 7856–7857.
https://doi.org/10.1182/blood-2022-159536
Published: 2022
Journal Articles

African American Race Is a Potential Favorable Biologic Factor That Impacts Clinical Outcome for Patients with Multiple Myeloma

Jeries Kort, Leland Metheny, Pingfu Fu, Shufen Cao, James J. Driscoll, Ehsan Malek
Journal: Blood
Blood (2022) 140 (Supplement 1): 7244–7245.
https://doi.org/10.1182/blood-2022-170717
Published: 2022
Journal Articles

Prognostic Value of Dynamic Monoclonal Protein Pattern on Probability of Myeloma Progression from the Precursor State

Jeries Kort, Ravikumar Kyasaram, Shufen Cao, Pingfu Fu, James J. Driscoll, Ehsan Malek
Journal: Blood
Blood (2021) 138 (Supplement 1): 3781.
https://doi.org/10.1182/blood-2021-153265
Published: 2021
Journal Articles

Safety and Efficacy of Replacing Vindesine with Vincristine in R-ACVBP Protocol for the Treatment of High-Grade B Cell Lymphoma

Rola El Sayed, MD, Haidar El Darsa, MD, Jeries Kort, MD, Farouk Al Chami, MD, Charafeddine Maya, Ali Bazarbachi, MD PhD, Iman Abou Dalle, MD, Jean Elcheikh, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 49–50.
https://doi.org/10.1182/blood-2020-142544
Published: 2020
Journal Articles

Health Care Burden of Monogammopathy of Renal Significance

Jeries Kort, MD, Paolo F Caimi, MD, Pingfu Fu, PhD, Shufen Cao, James Driscoll, Marcos de Lima, MD, Ehsan Malek, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 34–36.
https://doi.org/10.1182/blood-2020-139740
Published: 2020
Journal Articles

Analysis of Racial Differences in the Incidence of a Targetable Biomarker, t(11;14), in Patients with Multiple Myeloma

Fang Liu, MD, Jeries Kort, MD, Shashirekha Shetty, PhD, Ravikumar Kyasaram, John Shanahan, Timothy E. O'Brien, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 1–2.
https://doi.org/10.1182/blood-2020-140133
Published: 2020
Journal Articles

Development of a Machine Learning Algorithm for Rapid, Point-of-Care Prediction of Serum Monoclonal Proteins in Multiple Myeloma

Ehsan Malek, MD, Jeries Kort, MD, Gi-Ming Wang, PhD, Paolo F Caimi, MD, Kirsten M Boughan, DO, Stanton L. Gerson, MD, Brenda W. Cooper, MD, Molly M Gallogly, MDPhD, Benjamin K. Tomlinson, MD, Marcos de Lima, MD, Curtis Tatsuoka, PhD, James Driscoll
Journal: Blood
Blood (2020) 136 (Supplement 1): 13–15.
https://doi.org/10.1182/blood-2020-139733
Published: 2020